X
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.prnewswire.com/news-releases/isa-pharmaceuticals-reports-highlights-of-randomized-phase-2-cancer-vaccine-trial-in-head--neck-cancer-302011313.html
https://www.fiercebiotech.com/biotech/isa-sees-cancer-vaccine-fail-phase-2-fail-loses-regenerons-interest-still-plans-path-market
https://pharmafile.com/news/first-patient-dosed-in-phase-1-study-for-chronic-hepatitis-b-treatment/
https://www.prnewswire.com/news-releases/first-patient-with-chronic-hepatitis-b-dosed-with-isa104-in-first-in-human-phase-1-study-301913027.html
https://www.prnewswire.com/news-releases/the-combination-of-isa101b-and-libtayo-shows-promising-results-in-patients-whose-head-and-neck-cancer-progressed-on-anti-pd1-therapy-301841279.html
https://www.prnewswire.com/news-releases/isa-pharmaceuticals-to-present-first-clinical-trial-data-from-the-phase-ii-study-of-isa101b-and-libtayo-cemiplimab-combination-in-head-and-neck-cancer-at-the-asco-annual-meeting-2023-301833400.html
https://www.prnewswire.com/news-releases/isa-pharmaceuticals-to-present-pre-clinical-data-on-its-protective-slp-therapy-against-sars-cov-2-at-the-cimt-annual-meeting-301809137.html
https://www.prnewswire.com/news-releases/isa-pharmaceuticals-to-attend-and-present-at-upcoming-scientific-and-business-conferences-in-may-and-june-of-2023-301802174.html
https://www.prnewswire.com/news-releases/isa-pharmaceuticals-and-cancer-focus-fund-announce-5-million-investment-to-support-first-in-human-trial-of-isas-novel-immunotherapy-isa103-in-uveal-melanoma-301712573.html
https://www.clinicaltrialsarena.com/news/isa-hpv16-positive-opc-therapy/
Market Place
Share 
